NVP Infant-Dose Pouch

Ensuring that children have access to single dose Nevirapine shortly after birth is one of the greatest challenges within the prevention of mother to child transmission of HIV; at health facilities and even more so at home. Knowing that about 60% of the mothers in Africa deliver at home it is crucial to make the NVP suspension available outside structured healthcare settings.

Boehringer Ingelheim responds to this need by making a single dose pouch, developed by PATH with funding from USAID, available to all programs benefiting from Viramune® Donation Programme.

This self-sealing laminate pouch allows the mothers to bring the NVP suspension back home safely. Within the scope of the Viramune® Donation Programme health workers will fill a dispenser (content should be used within 2 months), with the VIRAMUNE® suspension, and seal both within the pouch. Both the VIRAMUNE® suspension and pouch are provided free of charge by Boehringer Ingelheim for PMTCT.